ATE422375T1 - Aktives medizinisches implantat, insbesondere vorrichtung zur stimulation, resynchronisation, defibrillation und/oder kardioversion, die mittel zur prädiktiven warnung über eine verschlimmerung des krankheitszustands des patienten umfasst - Google Patents

Aktives medizinisches implantat, insbesondere vorrichtung zur stimulation, resynchronisation, defibrillation und/oder kardioversion, die mittel zur prädiktiven warnung über eine verschlimmerung des krankheitszustands des patienten umfasst

Info

Publication number
ATE422375T1
ATE422375T1 AT07290705T AT07290705T ATE422375T1 AT E422375 T1 ATE422375 T1 AT E422375T1 AT 07290705 T AT07290705 T AT 07290705T AT 07290705 T AT07290705 T AT 07290705T AT E422375 T1 ATE422375 T1 AT E422375T1
Authority
AT
Austria
Prior art keywords
patient
contractility
excession
cardioversion
resynchronization
Prior art date
Application number
AT07290705T
Other languages
English (en)
Inventor
Cyrille Casset
Original Assignee
Ela Medical Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ela Medical Sa filed Critical Ela Medical Sa
Application granted granted Critical
Publication of ATE422375T1 publication Critical patent/ATE422375T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/362—Heart stimulators
    • A61N1/365—Heart stimulators controlled by a physiological parameter, e.g. heart potential
    • A61N1/36585—Heart stimulators controlled by a physiological parameter, e.g. heart potential controlled by two or more physical parameters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/362—Heart stimulators
    • A61N1/365—Heart stimulators controlled by a physiological parameter, e.g. heart potential
    • A61N1/36514—Heart stimulators controlled by a physiological parameter, e.g. heart potential controlled by a physiological quantity other than heart potential, e.g. blood pressure
    • A61N1/36521—Heart stimulators controlled by a physiological parameter, e.g. heart potential controlled by a physiological quantity other than heart potential, e.g. blood pressure the parameter being derived from measurement of an electrical impedance
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/362—Heart stimulators
    • A61N1/365—Heart stimulators controlled by a physiological parameter, e.g. heart potential
    • A61N1/36514—Heart stimulators controlled by a physiological parameter, e.g. heart potential controlled by a physiological quantity other than heart potential, e.g. blood pressure
    • A61N1/36557—Heart stimulators controlled by a physiological parameter, e.g. heart potential controlled by a physiological quantity other than heart potential, e.g. blood pressure controlled by chemical substances in blood

Landscapes

  • Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cardiology (AREA)
  • Engineering & Computer Science (AREA)
  • Physiology (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Electrotherapy Devices (AREA)
AT07290705T 2006-06-15 2007-06-07 Aktives medizinisches implantat, insbesondere vorrichtung zur stimulation, resynchronisation, defibrillation und/oder kardioversion, die mittel zur prädiktiven warnung über eine verschlimmerung des krankheitszustands des patienten umfasst ATE422375T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0605322 2006-06-15

Publications (1)

Publication Number Publication Date
ATE422375T1 true ATE422375T1 (de) 2009-02-15

Family

ID=37761896

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07290705T ATE422375T1 (de) 2006-06-15 2007-06-07 Aktives medizinisches implantat, insbesondere vorrichtung zur stimulation, resynchronisation, defibrillation und/oder kardioversion, die mittel zur prädiktiven warnung über eine verschlimmerung des krankheitszustands des patienten umfasst

Country Status (4)

Country Link
US (1) US7792574B2 (de)
EP (1) EP1867360B1 (de)
AT (1) ATE422375T1 (de)
DE (1) DE602007000529D1 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL188033A0 (en) * 2007-12-10 2008-12-29 Hadasit Med Res Service Method and system for detection of pre-fainting conditions
DE602008004206D1 (de) 2007-12-13 2011-02-10 Ela Medical Sa Medizinische Vorrichtung zur Bestimmung des Herzzustands eines Patienten, dem ein aktives Implantat zur biventrikulären Stimulation eingesetzt wurde
US8844525B2 (en) * 2008-07-25 2014-09-30 Resmed Limited Method and apparatus for detecting and treating heart failure
US20110230731A1 (en) * 2010-03-22 2011-09-22 General Electric Company Method, device and computer program product for determining an indicator of general clinical state
RU2603052C2 (ru) 2011-03-01 2016-11-20 Конинклейке Филипс Н.В. Обнаружение нарушений у пациента
EP2508227B1 (de) * 2011-04-06 2013-12-25 Sorin CRM SAS Implantierbare Herzprothese zur Resynchronisation des Herzens durch biventrikuläre Stimulation, die Mittel zur inversen Herzrekonfiguration umfasst
FR2986158A1 (fr) 2012-01-31 2013-08-02 Sorin Crm Sas Dispositif medical implantable actif comprenant des moyens de diagnostic de l'insuffisance cardiaque
EP2684515B1 (de) * 2012-07-13 2014-12-17 Sorin CRM SAS Aktive medizinische Vorrichtung, die Mittel zur Überwachung des Zustands eines Patienten mit Herzinsuffizienzrisiko umfasst
EP2769668B1 (de) 2013-02-26 2021-10-13 Sorin CRM SAS System zur adaptiven Diagnose von Herzinsuffizienz mittels Klassifikatoren und eines booleschen Entscheidungsbaums
EP2839859B1 (de) 2013-08-20 2016-04-27 Sorin CRM SAS Aktive medizinische Vorrichtung, insbesondere Einheit für kardiale Resynchronisationstherapie (CRT), die Alarmmittel zur Vorhersage einer kardialen Dekompensation im Fall einer zentralen Schlafapnoe umfasst
MX382711B (es) 2014-09-25 2025-03-13 Biora Therapeutics Inc Dispositivo de pildora electromecanica con capacidades de localizacion.
JP7153633B2 (ja) * 2016-08-18 2022-10-14 ビオラ・セラピューティクス・インコーポレイテッド サンプリングシステム、ならびに関連する材料および方法
CN115591091A (zh) 2016-09-09 2023-01-13 比奥拉治疗股份有限公司（Us） 用于递送可配发物质的机电可摄入装置
CA3046489A1 (en) 2016-12-07 2018-06-14 Progenity Inc. Gastrointestinal tract detection methods, devices and systems
EP3600009B1 (de) 2017-03-31 2020-12-30 Progenity, Inc. Schluckbare vorrichtung mit lokalisierungsfähigkeit
CN116726361A (zh) 2018-11-19 2023-09-12 比奥拉治疗股份有限公司 用生物治疗剂治疗疾病的方法和装置
EP4674473A1 (de) * 2024-07-04 2026-01-07 Sorin CRM SAS Energieeffiziente aktivitätsabhängige stimulation

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1245814B (it) 1991-05-21 1994-10-18 Sorin Biomedica Spa Dispositivo cardiostimolatore del tipo rate responsive
US5342404A (en) 1992-04-03 1994-08-30 Intermedics, Inc. Implantable medical interventional device
IT1256900B (it) 1992-07-27 1995-12-27 Franco Vallana Procedimento e dispositivo per rilevare la funzionalita` cardiaca.
IT1260692B (it) 1993-10-05 1996-04-22 Sorin Biomedica Spa Dispositivo per la determinazione della funzione miocardica e relativoprocedimento.
FR2735985B1 (fr) 1995-06-30 1997-12-19 Ela Medical Sa Dispositif medical implantable actif, notamment stimulateur cardiaque, asservi a au moins un parametre physiologique
US5792197A (en) * 1996-04-29 1998-08-11 Nappholz; Tibor A. Implanted cardiac device with means for classifying patient condition
FR2771298B1 (fr) 1997-11-25 2000-01-28 Ela Medical Sa Dispositif medical implantable actif, notamment stimulateur cardiaque, asservi a au moins un parametre physiologique
US6171256B1 (en) * 1998-04-30 2001-01-09 Physio-Control Manufacturing Corporation Method and apparatus for detecting a condition associated with acute cardiac ischemia
FR2780290B1 (fr) * 1998-06-26 2000-09-22 Ela Medical Sa Dispositif medical implantable actif asservi tel que stimulateur cardiaque, defibrillateur et/ou cardioverteur, notamment de type multisites
FR2803759B1 (fr) 2000-01-14 2002-02-22 Ela Medical Sa Dispositif medical implantable actif, notamment stimulateur cardiaque, defibrillateur et/ou dispositif multisite comportant des moyens de mesure d'impedance transvalvulaire
FR2806311B1 (fr) 2000-03-14 2002-10-18 Ela Medical Sa Dispositif medical implantable actif, notamment stimulateur cardiaque, defibrillateur et/ou cardioverteur et/ou dispositif multisite comportant des moyens de mesure de bioimpedance transseptale
US6658292B2 (en) * 2001-08-24 2003-12-02 Pacesetter, Inc. Detection of patient's position and activity status using 3D accelerometer-based position sensor
US6980851B2 (en) * 2001-11-15 2005-12-27 Cardiac Pacemakers, Inc. Method and apparatus for determining changes in heart failure status
FR2862543B1 (fr) * 2003-11-21 2010-09-24 Ela Medical Sa Dispositif medical implantable actif comprenant une fonction de suivi de l'activite sympathico-vagale par analyse de l'acceleration endocardiaque
DE102004034337A1 (de) * 2004-04-14 2005-11-03 Biotronik Gmbh & Co. Kg Elektrotherapiegerät
US8244355B2 (en) 2004-10-29 2012-08-14 Medtronic, Inc. Method and apparatus to provide diagnostic index and therapy regulated by subject's autonomic nervous system

Also Published As

Publication number Publication date
DE602007000529D1 (de) 2009-03-26
US7792574B2 (en) 2010-09-07
EP1867360B1 (de) 2009-02-11
EP1867360A3 (de) 2008-02-27
EP1867360A2 (de) 2007-12-19
US20070293736A1 (en) 2007-12-20

Similar Documents

Publication Publication Date Title
ATE422375T1 (de) Aktives medizinisches implantat, insbesondere vorrichtung zur stimulation, resynchronisation, defibrillation und/oder kardioversion, die mittel zur prädiktiven warnung über eine verschlimmerung des krankheitszustands des patienten umfasst
ATE417543T1 (de) Verwendung von ultraviolett, nahultraviolett und nahinfrarot-resonanzrmanspektroskopie und fluoresenzspektoskopie zur gewebeuntersuchung auf schockzustand, kritische krankheiten oder andere krankheitszustände
DE602008004206D1 (de) Medizinische Vorrichtung zur Bestimmung des Herzzustands eines Patienten, dem ein aktives Implantat zur biventrikulären Stimulation eingesetzt wurde
WO2008127388A3 (en) Use of quantum system identification and quantum control techniques for medical diagnostic and therapeutic purposes
WO2011141765A8 (en) Diagnostic classifications of pulse signal waveform data
DE60329165D1 (de) Detektion und/oder beobachtung von synuclein-assoziierten krankheiten
AU2003295644A1 (en) Diagnostic method for diseases by screening for hepcidin in human or animal tissues, blood or body fluids and therapeutic uses therefor
WO2008106396A3 (en) Method and system for monitoring oxygenation levels of a compartment for detecting conditions of a compartment syndrome
WO2005046570A3 (en) Human stem cell materials and methods
Lowenstein Paleodermatoses: lessons learned from mummies
WO2007089953A3 (en) Assessment of medical conditions
ATE480243T1 (de) Zusammensetzung zur verwendung bei diagnose der akuten verletzungen des zentralen nervensystems
ATE446788T1 (de) Implantierbare medizinische vorrichtung, insebesondere zur stimulation, resynchronisierung,defibrillation, und/oder cardioversion mit diagnostischen mitteln zur vorhersage des klinischen zustands des patienten
Park et al. Postoperative delirium in elderly patients with osteoarthritis surgery: incidence and risk factors
RU2067302C1 (ru) Способ прогнозирования эффективности плазмoфереза при эндогенных психозах с аффективными нарушениями
ATE387934T1 (de) Aktive implantierbare medizinische vorrichtung, insbesondere herzschrittmacher, resynchronisierer,defibrillator und/oder kardiovertierer, mit hilfsmitteln zur diagnose des zustands eines patienten
Jakovljević Current status of religion and spirituality in psychiatry.
ATE499611T1 (de) Verfahren zur diagnose von erkrankungen unter bestimmung von apolipoprotein c-i
DE102014019658B4 (de) Sauerstoffsättigungsdetektionsvorrichtung zur Detektion und Signalisierung der arteriellen Sauerstoffsättigung und Verfahren zur Steigerung der körperlichen Leistungsfähigkeit
WO2004091637A3 (en) System capable of treating and defining various diseases using stem cells
WO2007023392A3 (en) System and method for assessing cognitive function and measuring treatment efficacy
WO2008074813A3 (en) Optiogenin for the treatment of neural diseases
Lejeune et al. The challenge of assessment in rehabilitation.
WO2007013041A3 (en) Monitoring of cardiac natriuretic peptides during diagnosis, managment, and treatment of cardiac diseases
WO2007002571A3 (en) Use of an anti c5 complement antibody to treat patients with sickle cell disease

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties